Insmed (INSM) – FDA
-
Insmed (INSM) Reports AstraZeneca (AZN) Exercised Rights to Further Develop brensocatib
-
Insmed (INSM) Reports Positive Topline Data from Phase 3 ARISE study of ARIKAYCE
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to INSM Stock Lookup